Blog Articles
A scientific hub to keep you informed about our latest research and company updates.
![InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025](https://www.innoserlaboratories.com/wp-content/uploads/2025/03/ADPD-2025-InnoSer-Neurodegenerative-Disease-Models-400x250.png)
InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025
Top 4 Multi-Organ-on-a-Chip TissUse Assays and Why You Should Include them in Your Preclinical Research in 2025
How to Advance your Preclinical Research Using Mouse Data to Establish PK/PD Relationships
Exploring InnoSer’s Key In vitro Oncology Services: PD-1 PD-L1 Blockade Assay
Introduction to InnoSer’s Preclinical Epilepsy Research CRO Platform
The Application of Bioluminescence Imaging in Preclinical Oncology Research and Beyond
InnoSer to Present Novel Data at AD/PD 2024 Showcasing in Vitro Neurodegenerative Disease Modelling Capabilities
The Importance of Including Translational Kidney Function Readouts in Your Preclinical Research: Transdermal GFR Measurement
Translational In Vitro Assays to Screen Drug’s Efficacy for Alzheimer’s and Parkinson’s disease
Case Study: Acute Skin Inflammation Psoriasis Model
Novel Translational Readout: Auditory Event-Related Potentials EEG-Recording in Fragile X Syndrome Model
info@innoserlaboratories.com